Home › Oligodendroglioma › Ohio › Cleveland
Oligodendroglioma clinical trials in Cleveland, OH
3 studies for Oligodendroglioma are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
RecruitingPhase 2
- Cleveland Clinic, Cleveland
Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being
Recruiting
- University Hospitals Cleveland Medical Center, Cleveland
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Cleveland Clinic, Cleveland
Oligodendroglioma trials in other cities
- Houston, TX4 studies
- Boston, MA4 studies
- Miami, FL4 studies
- Philadelphia, PA3 studies
- Aurora, CO3 studies
- St. Louis, MO3 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)36 studies
- Breast Cancer33 studies
- Heart Failure31 studies
- Metastatic Cancer30 studies
- Prostate Cancer30 studies
- Ovarian Cancer29 studies
- Lung Cancer26 studies
- Colorectal Cancer25 studies
- Acute Myeloid Leukemia20 studies
- Head and Neck Squamous Cell Carcinoma20 studies
- Cardiovascular Disease20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.